These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 24440852)

  • 1. Tumor-induced perturbations of cytokines and immune cell networks.
    Burkholder B; Huang RY; Burgess R; Luo S; Jones VS; Zhang W; Lv ZQ; Gao CY; Wang BL; Zhang YM; Huang RP
    Biochim Biophys Acta; 2014 Apr; 1845(2):182-201. PubMed ID: 24440852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classification and biology of tumour associated stromal cells.
    Raffaghello L; Dazzi F
    Immunol Lett; 2015 Dec; 168(2):175-82. PubMed ID: 26145459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The continuum of cancer immunosurveillance: prognostic, predictive, and mechanistic signatures.
    Galon J; Angell HK; Bedognetti D; Marincola FM
    Immunity; 2013 Jul; 39(1):11-26. PubMed ID: 23890060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Vicious Cross-Talk between Tumor Cells with an EMT Phenotype and Cells of the Immune System.
    Romeo E; Caserta CA; Rumio C; Marcucci F
    Cells; 2019 May; 8(5):. PubMed ID: 31096701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The parallel lives of angiogenesis and immunosuppression: cancer and other tales.
    Motz GT; Coukos G
    Nat Rev Immunol; 2011 Sep; 11(10):702-11. PubMed ID: 21941296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restoring immunosurveillance by dendritic cell vaccines and manipulation of the tumor microenvironment.
    Vasaturo A; Verdoes M; de Vries J; Torensma R; Figdor CG
    Immunobiology; 2015 Feb; 220(2):243-8. PubMed ID: 25466585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer, obesity and immunometabolism - Connecting the dots.
    Dyck L; Lynch L
    Cancer Lett; 2018 Mar; 417():11-20. PubMed ID: 29253522
    [No Abstract]   [Full Text] [Related]  

  • 8. Crosstalk between Innate Lymphoid Cells and Other Immune Cells in the Tumor Microenvironment.
    Flores-Borja F; Irshad S; Gordon P; Wong F; Sheriff I; Tutt A; Ng T
    J Immunol Res; 2016; 2016():7803091. PubMed ID: 27882334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic cross-talk between tumor and immune cells in orchestrating the immunosuppressive network at the tumor microenvironment.
    Croci DO; Zacarías Fluck MF; Rico MJ; Matar P; Rabinovich GA; Scharovsky OG
    Cancer Immunol Immunother; 2007 Nov; 56(11):1687-700. PubMed ID: 17571260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor microenvironment: Interactions and therapy.
    Najafi M; Goradel NH; Farhood B; Salehi E; Solhjoo S; Toolee H; Kharazinejad E; Mortezaee K
    J Cell Physiol; 2019 May; 234(5):5700-5721. PubMed ID: 30378106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shaping the Immune Landscape in Cancer by Galectin-Driven Regulatory Pathways.
    Rabinovich GA; Conejo-García JR
    J Mol Biol; 2016 Aug; 428(16):3266-3281. PubMed ID: 27038510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fine-Tuning the Tumour Microenvironment: Current Perspectives on the Mechanisms of Tumour Immunosuppression.
    Armitage JD; Newnes HV; McDonnell A; Bosco A; Waithman J
    Cells; 2021 Jan; 10(1):. PubMed ID: 33401460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mast cell: insight into remodeling a tumor microenvironment.
    Liu J; Zhang Y; Zhao J; Yang Z; Li D; Katirai F; Huang B
    Cancer Metastasis Rev; 2011 Jun; 30(2):177-84. PubMed ID: 21267769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic cells and their role in tumor immunosurveillance.
    Strioga M; Schijns V; Powell DJ; Pasukoniene V; Dobrovolskiene N; Michalek J
    Innate Immun; 2013 Feb; 19(1):98-111. PubMed ID: 22732734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Tunable Diffusion-Consumption Mechanism of Cytokine Propagation Enables Plasticity in Cell-to-Cell Communication in the Immune System.
    Oyler-Yaniv A; Oyler-Yaniv J; Whitlock BM; Liu Z; Germain RN; Huse M; Altan-Bonnet G; Krichevsky O
    Immunity; 2017 Apr; 46(4):609-620. PubMed ID: 28389069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of tumor escape from immune system: role of mesenchymal stromal cells.
    Poggi A; Musso A; Dapino I; Zocchi MR
    Immunol Lett; 2014; 159(1-2):55-72. PubMed ID: 24657523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. License for destruction: tumor-specific cytokine targeting.
    Johansson A; Hamzah J; Ganss R
    Trends Mol Med; 2014 Jan; 20(1):16-24. PubMed ID: 24169116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrinsic modulation of lymphocyte function by stromal cell network: advance in therapeutic targeting of cancer.
    Görgün G; Anderson KC
    Immunotherapy; 2011 Oct; 3(10):1253-64. PubMed ID: 21995575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic instability in the tumor microenvironment: a new look at an old neighbor.
    Palumbo A; Da Costa Nde O; Bonamino MH; Pinto LF; Nasciutti LE
    Mol Cancer; 2015 Jul; 14():145. PubMed ID: 26227631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S100A4-neutralizing antibody suppresses spontaneous tumor progression, pre-metastatic niche formation and alters T-cell polarization balance.
    Grum-Schwensen B; Klingelhöfer J; Beck M; Bonefeld CM; Hamerlik P; Guldberg P; Grigorian M; Lukanidin E; Ambartsumian N
    BMC Cancer; 2015 Feb; 15():44. PubMed ID: 25884510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.